32
Participants
Start Date
June 30, 2007
Primary Completion Date
January 31, 2016
Study Completion Date
March 31, 2016
Clofarabine
Dose escalation of clofarabine on Days -9, -8, -7, -6, -5: 1 - 30 mg/m2; 2 - 40 mg/m2; 2 - 46 mg/m2; 3 - 52 mg/m2
Clofarabine
Use dose of clofarabine established in Part A to further define event free, disease free and overall survival.
New York Medical College, Vallhala
Lead Sponsor
Genzyme, a Sanofi Company
INDUSTRY
New York Medical College
OTHER